We had 80% power to exclude odds ratios for COPD for E292V heterozygotes of 1.3, for surfactant protein-B 121ins2 heterozygotes of 2.1, and for α1-antitrypsin ZZ homozygotes of 4.0. This evidence concerns the gene SFTPB and chronic obstructive pulmonary disease.